Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥110.78 Million ≈ $16.21 Million USD) by net assets (CN¥9.02 Billion ≈ $1.32 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Tianjin Zhongxin Pharmaceutical Group Co to measure how many days the company can operate on defensive assets alone.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AVIC Heavy Machinery Co Ltd SHG:600765	-0.015x
Vietjet Aviation JSC VN:VJC	0.062x
Puig Brands SA NYSE:PUGBY	N/A
SIMCERE PHARMAC. GRP LTD F:S2P	N/A
Shandong Shida Shenghua Chem SHG:603026	0.029x
COSCO SHIPPING Specialized Carriers Co Ltd SHG:600428	0.109x
TOMRA SYSTEMS ADR/1 NK 1 F:TMR0	0.094x
Standex International Corporation NYSE:SXI	0.028x

Annual Cash Flow Conversion Efficiency for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Tianjin Zhongxin Pharmaceutical Group Co.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥924.67 Million ≈ $135.31 Million	0.118x	+13.69%
2023-12-31	CN¥6.65 Billion ≈ $972.41 Million	CN¥688.49 Million ≈ $100.75 Million	0.104x	+0.23%
2022-12-31	CN¥6.55 Billion ≈ $958.76 Million	CN¥677.25 Million ≈ $99.10 Million	0.103x	-21.01%
2021-12-31	CN¥6.51 Billion ≈ $953.18 Million	CN¥852.40 Million ≈ $124.73 Million	0.131x	+15.96%
2020-12-31	CN¥5.95 Billion ≈ $870.66 Million	CN¥671.42 Million ≈ $98.25 Million	0.113x	+25.79%
2019-12-31	CN¥5.52 Billion ≈ $808.22 Million	CN¥495.49 Million ≈ $72.51 Million	0.090x	+29.50%
2018-12-31	CN¥5.05 Billion ≈ $739.62 Million	CN¥350.14 Million ≈ $51.24 Million	0.069x	+8165.98%
2017-12-31	CN¥4.63 Billion ≈ $676.85 Million	CN¥-3.97 Million ≈ $-581.32K	-0.001x	-100.88%
2016-12-31	CN¥4.30 Billion ≈ $629.56 Million	CN¥419.90 Million ≈ $61.44 Million	0.098x	+11.12%
2015-12-31	CN¥4.11 Billion ≈ $600.72 Million	CN¥360.58 Million ≈ $52.76 Million	0.088x	-9.77%
2014-12-31	CN¥2.95 Billion ≈ $431.19 Million	CN¥286.85 Million ≈ $41.98 Million	0.097x	+17.45%
2013-12-31	CN¥2.57 Billion ≈ $376.80 Million	CN¥213.44 Million ≈ $31.23 Million	0.083x	+807.71%
2012-12-31	CN¥2.28 Billion ≈ $333.46 Million	CN¥20.81 Million ≈ $3.04 Million	0.009x	-88.42%
2011-12-31	CN¥2.21 Billion ≈ $322.67 Million	CN¥173.88 Million ≈ $25.44 Million	0.079x	+18.36%
2010-12-31	CN¥2.09 Billion ≈ $305.38 Million	CN¥139.04 Million ≈ $20.35 Million	0.067x	+42.83%
2009-12-31	CN¥1.79 Billion ≈ $261.66 Million	CN¥83.41 Million ≈ $12.21 Million	0.047x	-55.90%
2008-12-31	CN¥1.47 Billion ≈ $215.50 Million	CN¥155.77 Million ≈ $22.79 Million	0.106x	+606.94%
2007-12-31	CN¥1.35 Billion ≈ $196.89 Million	CN¥20.13 Million ≈ $2.95 Million	0.015x	+175.03%
2006-12-31	CN¥1.41 Billion ≈ $206.07 Million	CN¥-28.08 Million ≈ $-4.11 Million	-0.020x	-114.84%
2005-12-31	CN¥1.95 Billion ≈ $285.17 Million	CN¥261.91 Million ≈ $38.33 Million	0.134x	+2304.03%
2004-12-31	CN¥1.88 Billion ≈ $274.74 Million	CN¥10.50 Million ≈ $1.54 Million	0.006x	-86.57%
2003-12-31	CN¥1.84 Billion ≈ $269.08 Million	CN¥76.57 Million ≈ $11.20 Million	0.042x	-62.51%
2002-12-31	CN¥1.69 Billion ≈ $247.19 Million	CN¥187.60 Million ≈ $27.45 Million	0.111x	+8.52%
2001-12-31	CN¥1.54 Billion ≈ $225.52 Million	CN¥157.73 Million ≈ $23.08 Million	0.102x	--

About Tianjin Zhongxin Pharmaceutical Group Corp Ltd

SHG:600329 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.16 Billion

CN¥21.57 Billion CNY

Market Cap Rank

#4859 Global

#886 in China

Share Price

CN¥37.84

Change (1 day)

+0.29%

52-Week Range

CN¥32.44 - CN¥50.05

All Time High

CN¥54.12